AU2021305085A1 — Contingent aid device, system, and method for communicating with an emergency contact
Assigned to Letsundoit LLC · Expires 2023-02-02 · 3y expired
What this patent protects
A contingent aid device, system, and method are disclosed including a cavity with lid to hold a medicine, a control module, a lid status sensor, a medicine status sensor, a user-activatable tactile input, a status indicator module, a display screen, a communication module, a glob…
USPTO Abstract
A contingent aid device, system, and method are disclosed including a cavity with lid to hold a medicine, a control module, a lid status sensor, a medicine status sensor, a user-activatable tactile input, a status indicator module, a display screen, a communication module, a global positioning system module, an altimeter, a voice-in module, an audio-out module, a digital-in module, and a power source, wherein the device is configured to, without further user-initiated instruction or action, initiate communication with an emergency contact following removal of the medicine from the cavity, following user activation of the user-activatable tactile input, following a first predetermined period of time after opening of the lid without removal of the medicine from the cavity, or following a second predetermined period of time after removal of the medicine from the cavity without user activation of the user-activatable tactile input confirming the medicine has been administered.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.